ECM
LFCR icon

Engine Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Engine Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-40,000
Closed -$375K – 52
2019
Q2 		$375K Buy
+40,000
New +$404K 0.18% 36

Other funds holding LFCR

WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WC
Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

Engine Capital Management's LFCR Position: Q3 2019 in Review

Engine Capital Management sold out of Lifecore Biomedical (LFCR) in Q3 2019, closing a stake of 40,000 shares — an estimated $375K sold.

Engine Capital Management first reported a position in LFCR in Q2 2019 and held it in 1 quarter. The position peaked at $375K in Q2 2019. 104 funds tracked by Wall St. Rank hold LFCR as of Q3 2019.

  • Engine Capital Management reported no remaining Lifecore Biomedical position as of Q3 2019 after selling out during the quarter.
  • Engine Capital Management sold 40,000 Lifecore Biomedical shares in Q3 2019, an estimated $375K.
  • Engine Capital Management first reported a position in Lifecore Biomedical in Q2 2019 and held it in 1 quarter.
  • Engine Capital Management's Lifecore Biomedical position peaked at $375K in Q2 2019.
  • 104 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2019.

Based on Engine Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.